{"title":"儿童组织细胞增多症的演变景观：十年的发现和创新。","authors":"Maurizio Aricò","doi":"10.3390/pediatric17030062","DOIUrl":null,"url":null,"abstract":"<p><p>Over the past decade, the field of childhood histiocytosis, particularly Langerhans cell histiocytosis (LCH), has undergone transformative changes. The integration of molecular genetics, targeted therapies, and refined diagnostic methodologies has revolutionized patient management and redefined disease classification. This editorial provides a comprehensive overview of the pivotal developments from 2015 to 2025, highlights ongoing challenges, and explores future directions in research and clinical care.</p>","PeriodicalId":45251,"journal":{"name":"Pediatric Reports","volume":"17 3","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12196344/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Evolving Landscape of Childhood Histiocytosis: A Decade of Discovery and Innovation.\",\"authors\":\"Maurizio Aricò\",\"doi\":\"10.3390/pediatric17030062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Over the past decade, the field of childhood histiocytosis, particularly Langerhans cell histiocytosis (LCH), has undergone transformative changes. The integration of molecular genetics, targeted therapies, and refined diagnostic methodologies has revolutionized patient management and redefined disease classification. This editorial provides a comprehensive overview of the pivotal developments from 2015 to 2025, highlights ongoing challenges, and explores future directions in research and clinical care.</p>\",\"PeriodicalId\":45251,\"journal\":{\"name\":\"Pediatric Reports\",\"volume\":\"17 3\",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12196344/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/pediatric17030062\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/pediatric17030062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
The Evolving Landscape of Childhood Histiocytosis: A Decade of Discovery and Innovation.
Over the past decade, the field of childhood histiocytosis, particularly Langerhans cell histiocytosis (LCH), has undergone transformative changes. The integration of molecular genetics, targeted therapies, and refined diagnostic methodologies has revolutionized patient management and redefined disease classification. This editorial provides a comprehensive overview of the pivotal developments from 2015 to 2025, highlights ongoing challenges, and explores future directions in research and clinical care.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
